Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases

Details for Australian Patent Application No. 2008266227 (hide)

Owner National Cheng Kung University

Inventors Chang, Ming-shi

Agent Pizzeys

Pub. Number AU-A-2008266227

PCT Pub. Number WO2008/157161

Priority 11/763,812 15.06.07 US

Filing date 11 June 2008

Wipo publication date 24 December 2008

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

14 January 2010 PCT application entered the National Phase

  PCT publication WO2008/157161 Priority application(s): WO2008/157161

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008266228-Dipeptide analogs as coagulation factor inhibitors

2008266219-Reactive amine catalysts for polyurethane foam